The NLRP3 Inflammasome in Periodontitis: A Critical Appraisal of Innate Immune Mechanisms Linking Microbial Challenge to Periodontal Inflammation and Alveolar Bone Loss

Abstract

Periodontitis is a dysbiosis-driven chronic inflammatory disease in which host immune activity, rather than microbial presence alone, determines the destruction of the tooth-supporting apparatus and the resorption of alveolar bone. The nucleotide-binding oligomerisation domain, leucine-rich repeat and pyrin domain-containing protein 3 (NLRP3) inflammasome has emerged as a prominent candidate for connecting the recognition of subgingival pathogens to the maturation of interleukin (IL)-1β and IL-18 and to the lytic, pro-inflammatory cell death known as pyroptosis. This critical narrative review examines whether the available evidence supports a causal and therapeutically tractable role for NLRP3 in periodontal tissue breakdown, or whether current enthusiasm outpaces the data. Drawing on mechanistic, preclinical and human studies retrieved through structured searching of biomedical databases, the review synthesises how periodontal bacteria engage, subvert or suppress the inflammasome; which periodontal cell populations contribute to inflammasome output; and how NLRP3 activity is translated, or fails to translate, into osteoclast-driven bone loss. A consistent association between inflammasome components and periodontal inflammatory burden is evident across gingival tissue, gingival crevicular fluid, saliva and serum, and genetic and treatment-response data reinforce a correlative link. The causal picture is far less settled. Keystone pathogens such as Porphyromonas gingivalis frequently restrain rather than ignite the inflammasome, and genetic deletion studies in animal models yield directionally conflicting effects on alveolar bone, with protective, dispensable and pathogenic roles all reported. These discrepancies appear to reflect differences in bacterial challenge, cell type, disease phase and the balance between canonical and non-canonical signalling, rather than simple experimental error. Pharmacological inhibition is promising but almost entirely preclinical, and recently recognised sex-dependent and non-pyroptotic functions complicate translation. The review concludes that NLRP3 is best regarded as a context-dependent amplifier of periodontal inflammation whose therapeutic exploitation will require stratified, mechanism-specific investigation rather than uniform inhibition.